Nu Skin Enterprises (NYSE:NUS) Announces Earnings Results, Beats Expectations By $0.04 EPS

Nu Skin Enterprises (NYSE:NUS) released its quarterly earnings data on Wednesday. The company reported $0.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.04, Briefing.com reports. The firm had revenue of $417.31 million during the quarter, compared to analysts’ expectations of $426.55 million. Nu Skin Enterprises had a return on equity of 10.73% and a net margin of 0.44%. The business’s revenue for the quarter was down 13.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.37 earnings per share.

Nu Skin Enterprises Stock Up 1.0 %

NYSE NUS traded up $0.12 during trading on Thursday, hitting $12.54. 347,028 shares of the company traded hands, compared to its average volume of 724,981. Nu Skin Enterprises has a 12 month low of $11.73 and a 12 month high of $38.23. The business has a fifty day simple moving average of $12.66 and a 200 day simple moving average of $15.89. The company has a current ratio of 2.13, a quick ratio of 1.28 and a debt-to-equity ratio of 0.58. The company has a market capitalization of $619.73 million, a P/E ratio of 70.56 and a beta of 1.13.

Nu Skin Enterprises Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 6th. Shareholders of record on Monday, February 26th were issued a dividend of $0.06 per share. The ex-dividend date was Friday, February 23rd. This represents a $0.24 annualized dividend and a yield of 1.91%. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 133.34%.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. StockNews.com cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Saturday, February 24th. DA Davidson cut their target price on Nu Skin Enterprises from $15.50 to $12.50 and set a “neutral” rating on the stock in a report on Thursday. Four research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $20.83.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.